ABL Bio-Technologies (Delisted) share price
BSE: 526955
ABL Bio-Technologies Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995
Last traded ₹0.81 on 11 Jul 2016
Delisted on 4 Jul 2018.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.
Nov 2016
Oct 2016
22 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
21 Oct · Limited Review Report for June 30, 2016
Sep 2016
Aug 2016
Results for the quarter to Sep 2016
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- −₹0.03 Cr
- Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line. Earnings per share in the glossary
- −₹0.04
From revenue to net profit, ₹ crore
- Depreciation0.0
- Profit before tax0.0
- Net profit0.0
ABL Bio-Technologies results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Sep 2016. Results for the quarter to Dec 2016 were due by 14 Feb 2017, 45 days after it ends. Every company's dates are on the results calendar.
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
- Loss
Peak revenue ₹0.00 Cr, quarter to Dec 2013A loss in 11 of the 11 quarters with results on record
Operating and net margin by quarter, per cent
- Operating margin
- Net margin
| ₹ crore | Dec 2011 | Mar 2012 | Jun 2012 | Sep 2012 | Dec 2012 | Mar 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | – | – | – | – | – | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | 0.01 | 0.01 | – | 0.02 | – | 0.02 | 0.02 | 0.02 | 0.02 | – | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | – | 0.03 | 0.03 |
| Profit before one-off items and taxProfit before one-off items and tax. Profit before tax as it would be without the one-off items below it, as the company states it. Profit before one-off items and tax in the glossary | −0.09 | −0.13 | – | −0.04 | – | −0.04 | −0.03 | −0.04 | −0.04 | −0.04 | −0.04 | −0.04 | −0.04 | −0.04 | −0.03 | −0.03 | – | −0.03 | −0.03 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. Exceptional items in the glossary | −0.02 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Profit before tax | −0.11 | −0.13 | – | −0.04 | – | −0.04 | −0.03 | −0.04 | −0.04 | −0.04 | −0.04 | −0.04 | −0.04 | −0.04 | −0.03 | −0.03 | – | −0.03 | −0.03 |
| Net profit | −0.11 | −0.13 | – | −0.04 | – | −0.04 | −0.03 | −0.04 | −0.04 | −0.04 | −0.04 | −0.04 | −0.04 | −0.04 | −0.03 | −0.03 | – | −0.03 | −0.03 |
| Net margin | – | – | – | – | – | −557.1% | −1,700.0% | −1,850.0% | −1,850.0% | −2,050.0% | −2,000.0% | −2,000.0% | −2,100.0% | −1,850.0% | −1,650.0% | −1,700.0% | – | – | – |
| Earnings per share | – | −₹0.16 | – | −₹0.05 | – | −₹0.05 | −₹0.04 | – | −₹0.04 | – | – | – | – | −₹0.05 | −₹0.05 | −₹0.04 | – | −₹0.04 | −₹0.04 |
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarters to Jun 2012, Dec 2012 and Mar 2016.
ABL Bio-Technologies results by half year
Standalone: the listed company alone, without its subsidiaries. The half years to Sep 2013 in the same span that the quarters on record do not fully cover.
| ₹ crore | Sep 2013 |
|---|---|
| Revenue from operations | 0.00 |
| Depreciation and amortisation | 0.04 |
| Profit before tax | −0.07 |
| Net profit | −0.07 |
| Net margin | −2,400.0% |
| Earnings per share | −₹0.05 |
Earnings per share in rupees, restated for later splits and bonuses.
8 years at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
- Loss
Peak revenue ₹20 Cr, year to Mar 2008; lowest ₹0.01 Cr, year to Mar 2013A loss in 7 of the 8 years shown
Operating and net margin, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
Results for the year to Mar 2015
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Revenue0.0
- Depreciation−0.1
- Profit before tax−0.2
- Net profit−0.2
Profit and loss
Standalone, ₹ crore, years to March.
| ₹ crore | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 20.0 | 9.4 | 2.5 | 0.0 | – | 0.0 | 0.0 | 0.0 |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | 16.9 | 8.9 | 3.1 | – | – | – | – | – |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | 10.0 | 4.4 | 1.2 | 0.0 | – | – | – | – |
| Operating profit before depreciationOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax. Operating profit before depreciation (EBITDA) in the glossary | 3.1 | 0.5 | −0.6 | – | – | – | – | – |
| Operating margin | 15.5% | 5.6% | −25.8% | – | – | – | – | – |
| Depreciation and amortisation | 0.2 | 0.2 | 0.2 | 0.1 | – | – | 0.1 | 0.1 |
| Operating profit after depreciationOperating profit after depreciation (EBIT). Operating profit before depreciation, less depreciation and amortisation. Operating profit after depreciation (EBIT) in the glossary | 2.9 | 0.3 | −0.9 | – | – | – | – | – |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | 0.1 | 0.0 | 0.0 | 0.0 | – | – | – | – |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. Finance costs in the glossary | 0.9 | 1.1 | 0.9 | – | – | – | – | – |
| Profit before one-off items and tax | – | −0.8 | −1.8 | −0.4 | −0.3 | −0.1 | −0.1 | −0.2 |
| One-off items | – | – | – | −0.1 | – | – | – | – |
| Profit before tax | 2.1 | −0.8 | −1.8 | −0.5 | −0.3 | −0.1 | −0.1 | −0.2 |
| Tax | 0.3 | 0.0 | – | – | – | – | – | – |
| Net profit | 1.8 | −0.8 | −1.8 | −0.5 | −0.3 | −0.1 | −0.1 | −0.2 |
| Net margin | 9.0% | −8.9% | −72.3% | −1,181.0% | – | −2,057.1% | −2,085.7% | −2,342.9% |
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2011, Mar 2014 and Mar 2015: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2012: the statement does not state its revenue, finance costs or depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2013: the statement does not state its finance costs or depreciation, which operating profit is worked out from, so operating profit is not given.
Ratios
Standalone, years to March.
| Ratio | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue growthRevenue growth. This year's revenue less last year's, divided by last year's, times 100; blank where last year's is not above nought. Revenue growth in the glossary | – | −52.9% | −73.5% | −98.3% | – | – | 0.0% | 0.0% |
| Operating profit growthOperating profit growth. This year's operating profit before depreciation less last year's, divided by last year's, times 100; blank where last year's is not above nought. Operating profit growth in the glossary | – | −83.0% | – | – | – | – | – | – |
| Interest coverInterest cover. Operating profit after depreciation divided by finance costs: how many times over the profit pays the interest bill. Interest cover in the glossary | 3.0 | 0.3 | – | – | – | – | – | – |
Interest cover is left blank for the year to Mar 2010: operating profit after depreciation is a loss, and a loss covers no interest bill.
Growth and returns over 3, 5 and 10 years
Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2015.
| Measure | 5 years | 3 years |
|---|---|---|
| Revenue growth, yearly rateRevenue growth, yearly rate. 3 years: Revenue in the latest year ÷ revenue in the year three years before, to the power of one third, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 5 years: Revenue in the latest year ÷ revenue in the year five years before, to the power of one fifth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 10 years: Revenue in the latest year ÷ revenue in the year ten years before, to the power of one tenth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. | −69.1% | – |
| Net margin, averageNet margin, average. 3 years: The plain average of the yearly net profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly net profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly net profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | −1,916.7% | −2,161.9% |
Accounting checks
Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.
| Check | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|
| Effective tax rateEffective tax rate. Tax charged as a percentage of profit before tax. Effective tax rate in the glossaryPublished threshold 17.16 per cent | 13.04 | – | – | – | – | – | – | – |
A threshold marked as ours has no published figure; it is the line we read the check against.
Where the return came from
Yearly rates to Mar 2015, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −44.7% | – | – | 0.0% |
| 3 years | −13.3% | – | – | 0.0% |
| 5 years | −30.5% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
ABL Bio-Technologies share price by year
Each calendar year to 2016.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2016 | 0.81 | −15.6% | 0.96 | 0.76 |
| 2015 | 0.96 | −63.5% | 4.67 | 0.96 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The close is the year's last trade for 2016 (11 Jul 2016) and 2015 (18 Dec 2015).
Recent sessions
The 10 trading days to 11 Jul 2016, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 11 Jul 2016 | 0.80 | 0.81 | 0.75 | 0.81 | 0.79 | 37,663 |
| 4 Jul 2016 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 900 |
| 20 Jun 2016 | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 | 50 |
| 13 Jun 2016 | 0.80 | 0.80 | 0.77 | 0.79 | 0.79 | 13,719 |
| 9 May 2016 | 0.76 | 0.80 | 0.76 | 0.80 | 0.77 | 9,500 |
| 2 May 2016 | 0.76 | 0.80 | 0.76 | 0.80 | 0.80 | 15,100 |
| 11 Apr 2016 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 5,000 |
| 4 Apr 2016 | 0.73 | 0.79 | 0.73 | 0.79 | 0.79 | 9,134 |
| 28 Mar 2016 | 0.76 | 0.76 | 0.76 | 0.76 | 0.76 | 550 |
| 21 Mar 2016 | 0.80 | 0.80 | 0.76 | 0.80 | 0.80 | 40,210 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 526955
- ISIN
- INE707D01016
- Website
- www.ablbiotechnologies.com
- CIN
- L52599TN1992PLC022340
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1992
- Registered office
- No. 01, Wallers Lane, 1st Floor, Room No. 3, Mataji Complex, Near India Silk House, Mount Road, Chennai 600002, Tamil Nadu
- Share registrar
- Cameo Corporate Services Ltd
- Keeps the register of shareholders and handles transfers and dividend payments